Putnam Investments’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
Other funds holding AERI
DM
FCMI
WRF
PHS
FCMI
FCMI
Putnam Investments's AERI Position: Q3 2019 in Review
Putnam Investments sold out of Aerie Pharmaceuticals (AERI) in Q3 2019, closing a stake of 62,113 shares — an estimated $1.84M sold.
Putnam Investments first reported a position in AERI in Q4 2013 and held it in 19 quarters. The position peaked at $12.3M in Q3 2016. 167 funds tracked by Wall St. Rank hold AERI as of Q3 2019.
- Putnam Investments reported no remaining Aerie Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
- Putnam Investments sold 62,113 Aerie Pharmaceuticals shares in Q3 2019, an estimated $1.84M.
- Putnam Investments first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 19 quarters.
- Putnam Investments's Aerie Pharmaceuticals position peaked at $12.3M in Q3 2016.
- 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2019.
Based on Putnam Investments's 13F filing for Q3 2019, filed 14 Nov 2019.